Sign In

Karen Pomeranz

Pharma Strategy Consultant

Karen Pomeranz is a Strategy Consultant at Putnam, a role she has held since December 2021. In her current position, she focuses on strategic initiatives within the pharmaceutical sector. Prior to joining Putnam, she worked as a Senior Manager in Research & Development at Evaluate Ltd from April 2021 to April 2022, and before that, she served as a Managing Analyst in Product Development at the same company for over four years. Her earlier experience includes a position as a Senior Business Insights Analyst in oncology at Decision Resources Group from January 2011 to January 2017.

Pomeranz holds a PhD in Molecular Medicine from Imperial College London, where her research focused on the regulation of FoxO transcription factors in breast cancer. She is proficient in both English and Hebrew, reflecting her diverse linguistic capabilities.1

Highlights

Jun 12 · afpglobal.org
[PDF] 2023 Annual Report - Association of Fundraising Professionals
2024 Webinar: Institutional Challenge Grant, An Overview of the ...
Feb 27 · cii.org
[PDF] CII-2024-Spring-Conference-Program.pdf

Related Questions

What specific projects has Karen Pomeranz worked on at Putnam?
How did Karen Pomeranz's experience at Evaluate Ltd prepare her for her role at Putnam?
What are some notable achievements in Karen Pomeranz's career?
How does Karen Pomeranz's background in molecular medicine influence her strategy consulting work?
What are the main industries Karen Pomeranz has worked in?
K
Add to my network

Experience

Strategy Consultant at Putnam since December 2021
Senior Manager at Evaluate Ltd (Apr 2021 - Apr 2022), Managing Analyst (Feb 2017 - Apr 2021), Senior Business Insights Analyst at Decision Resources Group (Jan 2011 - Jan 2017)

Education

PhD in Molecular Medicine from Imperial College London

Location

United Kingdom